A Study of Docetaxel Polymeric Micelles for Injection in Patients With Advanced Solid Tumors

PHASE2UnknownINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

March 31, 2024

Conditions
Advanced Solid Tumors
Interventions
DRUG

Docetaxel Polymeric Micelles for Injection

Docetaxel polymeric micelles,usage and quantity of Docetaxel polymeric micelles follows the clinical study proctol,not published.

Trial Locations (10)

200123

Shanghai East Hospital, Shanghai

233099

The First Affiliated Hospital of Bengbu Medical College, Bengbu

250117

Shandong Cancer Hospital, Jinan

300181

Tianjin Medical University Cancer Institute&Hospital, Tianjin

321099

Jinhua Municipal Hospital Medical Group, Jinhua

330029

Jiangxi Cancer Hospital, Nanchang

410031

Hunan Cancer Hospital, Changsha

450003

Henan Cancer Hospital, Zhengzhou

450052

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

050011

The Forth Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY